With the support of AdvaMed’s membership, Scott Whitaker signed the CEO Action for Diversity and Inclusion pledge, the largest CEO-driven business commitment to advance diversity and inclusion within the workplace.
The Business Roundtable (BRT) recently released a brief but powerful “Statement on the Purpose of a Corporation,” which reinforces the importance of serving all company stakeholders, even as each company serves its own corporate purpose.
Widespread concern has been raised about political misinformation, which can result in greater polarization between the parties or less trust in government. In many cases, however, the subject of misinformation is medical care, including the safety of FDA-approved or cleared medical devices and drugs. The result of this deception can be much more serious – including risk to health and even loss of life.
The Washington Post recently published an opinion piece by critic Jeanne Lenzer and a colleague which contained misleading and inaccurate claims regarding the safety of medical devices and FDA’s oversight of these products. I want to set the record straight so that patients can have confidence in the safety and effectiveness of the medical devices they depend on to live longer, healthier, more productive lives.
Last week, an article by Barbara Bridgman Perkins, PhD, was published in the Washington Post admonishing the relationships between industry and health care providers to advance radiotherapy treatment. Here is what I submitted in response.